Taiho Pharmaceutical Licensed To Develop And Sell ABRAXANE Anti-Cancer Agent By American BioScience, Inc.

November 21, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Tokyo (JCN) Nov 21, 2005- Taiho Pharmaceutical announced on November 16 that it has signed a licensing agreement with American BioScience for ABRAXANE, an anti-cancer agent. Under the agreement terms, Taiho will develop and sell the agent in Japan.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia